Font Size: a A A
Keyword [in-stent restenosis]
Result: 181 - 200 | Page: 10 of 10
181. Risk Factors Of In-stent Restenosis After Carotid Artery Stenting:A Meta-analysis
182. Risk Factors Analysis Of Stent Fracture After Superficial Femoral Artery And Proximal Popliteal Artery Stenting
183. New Treatment Strategy Of PCI-clinical Research Analysis Of Drug Coated Balloon And Bioresorbable Vascular Scaffold
184. Application Of MSCT To Explore The Correlation Between In-stent Restenosis And Preoperative Coronary Artery Disease After PCI
185. Expression And Clinical Significance Of RNCR3 In Patients With Coronary In-stent Restenosis
186. Analysis Of The Correlation Between LncRNA SENCR And In-Stent Restenosis After Percutaneous Coronary Intervention
187. Correlation Between Severity Of In-stent Restenosis And Glycosylated Hemoglobin In Patients With Acute Myocardial Infarction After PCI
188. Application Research Of Drug-coated Balloon In Endovascular Treatment Of Postoperative In-stent Restenosis In Patients With Arteriosclerosis Obliterans In Lower Extremity
189. Comparison Of OCT Imaging Characteristics Of The In-stent Restenosis In Different Angiographic Classifications And Different Periods
190. The Effect Of Lp(a)on In-stent Restenosis And Development Of Non-Target Coronary Lesions In CAD Patients With Drug-Eluting Stents
191. Influence Of Depression Disorder On In-stent Restenosis And Activator Protein-1 In Patients After PCI
192. The Predictive Value Of Epicardial Adipose Tissue And Inflammatory Factors For Restenosis In Stents
193. Clinical And Imaging Follow-up Study On Endovascular Stenting Of Extracranial Vertebral Artery Stenosis
194. The Analysis Of Risk Factors For In-stent Restenosis After Vertebral Artery Stenting
195. Factors Influencing In-Stent Restenosis After Percutaneous Coronary Intervention
196. Effect Of Taurours Deoxycholic Acid On In-Stent Restenosis By Regulating Endoplasmic Reticulum Stress
197. The Diagnostic Performance And Clinical Application Of Cardiac CT In Coronary Artery Diseases
198. Analysis Of The Influencing Factors Of The Restenosis In Coronary Drug Eluting Stents
199. Study Of Drug Eluting Stent And Angioplasty For The Treatment Of Coronary Heart Disease In-stent Restenosis
200. Clinical Application Of Rotarex System In The Reatment Of In-stent Restenosis At The Superficial Femoral Artery
  <<First  <Prev  Next>  Last>>  Jump to